Radiopharm Theranostics’ fight against cancer has taken a vital step forwards after the completion of a phase 1 imaging study of 40 breast cancer patients in Shanghai. According to the company, the procedure delivered uniformly excellent and easy to interpret results. Radiopharm is now looking to accelerate the development of its “RAD201” cancer fighting process and fire up a new therapy…
